Message Number: FHL3218 | New FHL Archives SearchFrom: Sukie Crandall
Date: Sat, 08 Dec 2007 01:34:17 -0500
To: ferrethealth@yahoogroups.com
Subject: [ferrethealth] some new abstracts
BEGIN QUOTED ABSTRACTS OR STUDY NAMES WHEN NO ABSTRACT
Parasitol Res. 2007 Aug;101 Suppl 1:57-62.
Imidacloprid plus Moxidectin to Prevent Heartworm Infection=20
(Dirofilaria immitis) in Ferrets.
Schaper R, Heine J, Arther RG, Charles SD, McCall J.
Bayer HealthCare AG, Animal Health, Leverkusen, Germany
Ferrets are susceptible to Dirofilaria immitis infection and develop a=20
disease comparable to that in cats and dogs. Treatment options are=20
limited, thus prevention would be a viable alternative. A study was=20
conducted to evaluate the efficacy of a combination of 10% w/v=20
imidacloprid plus 1.0% w/v moxidecin spot-on to prevent patent D.=20
immitis infection in experimentally infected ferrets when administered=20
once 30 days post-infection. Twelve ferrets were acclimated to the=20
study facility for seven days. The ferrets were free of heartworm=20
infection prior to the artificial infection, as demonstrated by=20
negative test results onmicrofilarial and antigen tests. On study day=20
-30, the twelve ferrets were artificially infected with 25 infective,=20
thirdstage larvae of D. immitis. On study day -1, the twelve ferrets=20
were randomised and allocated to two study groups so that each group=20
contained six ferrets. On study day 0, the animals assigned to group 1=20
were treated with a combination of 10% imidacloprid / 1% moxidectin at=20
a dose of 0.4 ml per ferret. The animals assigned to group 2 served as=20
untreated controls. On study day 124, the ferrets in both study groups=20
were euthanised and necropsied to determine the worm burden. Ferrets=20
in the control group (group 2) were adequately infected with D.=20
immitis at necropsy to allow assessment of the treatment group in this=20
study (GM =3D 17.2worms). The efficacy of a combination of 10%=20
imidacloprid / 1.0% moxidecin against artificial infections with D.=20
immitis in ferrets was 100% when administered once, at a target dosage=20
of 0.4 ml, 30 days post-infection. No adverse events were observed=20
which were considered to be treatment related.
PMID: 17661108 [PubMed - in process]
Vet Rec. 2007 Dec 1;161(22):759-60.
Segmental atresia of the uterus associated with hydrometra in a ferret.
Batista-Arteaga M, Alamo D, Herr=E1ez P, Santana M, Rodr=EDguez F, Ni=F1o T=
,=20
Gracia A.
Unit of Reproduction and Obstetrics, Las Palmas Veterinary College,=20
University of Las Palmas de Gran Canaria, Trasmonta=F1a 35416 Arucas,=20
Las Palmas, Spain.
PMID: 18056015 [PubMed - in process]
END QUOTES
There is also one on cortical disruption that probably won't be of=20
interest to most but those who want it can look in Exp Neurol. 2007=20
Oct 23 for cortical dysplasia.
Sukie (not a vet)
Recommended ferret health links:
http://pets.groups.yahoo.com/group/ferrethealth/
http://ferrethealth.org/archive/
http://www.afip.org/ferrets/index.html
http://www.miamiferret.org/fhc/
http://www.ferretcongress.org/
http://www.trifl.org/index.shtml
http://homepage.mac.com/sukie/sukiesferretlinks.html
[Non-text portions of this message have been removed]
Yahoo! Groups Links
<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/ferrethealth/
<*> Your email settings:
Individual Email | Traditional
<*> To change settings online go to:
http://groups.yahoo.com/group/ferrethealth/join
(Yahoo! ID required)
<*> To change settings via email:
mailto:ferrethealth-digest@yahoogroups.com
mailto:ferrethealth-fullfeatured@yahoogroups.com
<*> To unsubscribe from this group, send an email to:
ferrethealth-unsubscribe@yahoogroups.com
<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/
Send comments to Pam at pjdutche@email.unc.edu. Please note that this address is only useful for questions about the FHL archive. Questions about ferret health, or those intended for the FHL, should be sent to the Ferret Health List.